Volume 74, Pages S4-S9 (December 2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease  Victoria Cachofeiro, Marian Goicochea, Soledad García de Vinuesa, Pilar Oubiña, Vicente Lahera, José Luño  Kidney International  Volume 74, Pages S4-S9 (December 2008) DOI: 10.1038/ki.2008.516 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Bars represent plasma levels of lipid hydroperoxide (LPO, upper panel), oxidized low-density lipoprotein cholesterol (ox-LDL, middle panel), and total antioxidant capacity (TAC, lower panel) in subjects with normal renal function (CT) or patients with chronic kidney disease (CKD, stages 2–4) at baseline or after 6 months (CDK-ATV) with atorvastatin treatment (20mg/day). Data are average±s.d. *P<0.001 vs CT; §P<0.05 vs CDK. Kidney International 2008 74, S4-S9DOI: (10.1038/ki.2008.516) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Line segments and bar represent plasma levels of C-reactive protein (CRP upper panel), interleukin 1β (IL-1β, middle panel), and tumor necrosis factor-α (TNF-α, lower panel) in subjects with normal renal function (CT) or patients with chronic kidney disease (CKD, stages 2–4). Data are average±s.d. or median (25th–75th percentile, in the case of CRP). *P<0.001 vs CT. Kidney International 2008 74, S4-S9DOI: (10.1038/ki.2008.516) Copyright © 2008 International Society of Nephrology Terms and Conditions